addnok n 2.0/0.5 (buprenorphine hcl & naloxone tablet
rusan pharma ltd. rusan pharma ltd. address:58 / d, govt. - buprenorphine hcl & naloxone hcl tablets - tablet - buprenorphine hydrochloride ep eq to - buprenorphine combinations
bupensan duo 2 mg0.5 mg
a.l. medi-market ltd. - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - tablets sublingual - naloxone as hydrochloride dihydrate 0.5 mg; buprenorphine as hydrochloride 2 mg - buprenorphine, combinations - bupensan duo 2 mg/0.5 mg is indicated for substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse.treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction
bupensan duo 8 mg2 mg
a.l. medi-market ltd. - buprenorphine as hydrochloride; naloxone as hydrochloride dihydrate - tablets sublingual - naloxone as hydrochloride dihydrate 2 mg; buprenorphine as hydrochloride 8 mg - buprenorphine, combinations - bupensan duo 8 mg/2 mg is indicated for substitution treatment for opioid drug dependence, within a framework of medical, social and psychological treatment. the intention of the naloxone component is to deter intravenous misuse.treatment is intended for use in adults and adolescents over 15 years of age who have agreed to be treated for addiction
libroxar 8 mg/2 mg sublingual tablets
ej busuttil ltd busuttil buildings, triq l-ghadam, central business district zone 1, birkirkara, cbd 1060, malta - sublingual tablet - buprenorphine hydrochloride 8 mg naloxone hydrochloride dihydrate 2 mg - other nervous system drugs
libroxar 2 mg/0.5 mg sublingual tablets
ej busuttil ltd busuttil buildings, triq l-ghadam, central business district zone 1, birkirkara, cbd 1060, malta - sublingual tablet - naloxone hydrochloride dihydrate 0.5 mg buprenorphine hydrochloride 2 mg - other nervous system drugs
suboxone 2/0.5
pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine hydrochloride 2.16mg equivalent to 2 mg buprenorphine; naloxone hydrochloride dihydrate 0.61mg equivalent to 0.5 mg naloxone - sublingual tablet - 2mg/0.5mg - active: buprenorphine hydrochloride 2.16mg equivalent to 2 mg buprenorphine naloxone hydrochloride dihydrate 0.61mg equivalent to 0.5 mg naloxone excipient: acesulfame potassium citric acid lactose monohydrate lemon flavour phs-020484 magnesium stearate maize starch mannitol povidone sodium citrate dihydrate - treatment of opiate dependence, within a framework of medical, social and psychological treatment. naloxone is included in suboxone to deter intravenous misuse of the product.
suboxone 8/2
pharmacy retailing (nz) ltd t/a healthcare logistics - buprenorphine hydrochloride 8.64mg equivalent to 8 mg buprenorphine; naloxone hydrochloride dihydrate 2.44mg equivalent to 2 mg naloxone - sublingual tablet - 8mg/2mg - active: buprenorphine hydrochloride 8.64mg equivalent to 8 mg buprenorphine naloxone hydrochloride dihydrate 2.44mg equivalent to 2 mg naloxone excipient: acesulfame potassium citric acid lactose monohydrate lemon flavour phs-020484 magnesium stearate maize starch mannitol povidone sodium citrate dihydrate - treatment of opiate dependence, within a framework of medical, social and psychological treatment. naloxone is included in suboxone to deter intravenous misuse of the product.
subutex sublingual 0,4 mg tablet
adcock ingram critical care (pty) ltd - tablet - see ingredients - each tablet contains buprenorphine hydrochloride equivalent to buprenorphine 0,4 mg
subutex sublingual 2,0 mg tablet
adcock ingram critical care (pty) ltd - tablet - see ingredients - each tablet contains buprenorphine hydrochloride equivalent to buprenorphine 2,0 mg
subutex sublingual 8,0 mg tablet
adcock ingram critical care (pty) ltd - tablet - see ingredients - each tablet contains buprenorphine hydrochloride equivalent to buprenorphine 8,0 mg